BCAT vs NTLA Comparison

BlackRock Capital Allocation Trust, now BlackRock Capital Allocation Term Trust, is a diversified, closed-end management investment company. Its investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests in a portfolio of both equity and debt securities of companies from different sectors such as Information Technology, Financials, Industrials, Communication, Health Care, etc. It also utilizes an option-writing (selling) plan in an effort to generate current gains from option premiums and to enhance its risk-adjusted returns.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.